Oncorena AB
556864-0808ActiveDeveloping a breakthrough treatment for metastatic renal cancer using orellanine.
Oversikt
- 1–4
- Ansatte
- ≤1t SEK
- Omsetning
- 2011
- Grunnlagt
Nøkkelbeslutningstakere
Börje Haraldsson
CEO
Susanna Dahlgren
Chief Operating Officer
Åsa Holmgren
Head of Regulatory Affairs
Beskrivelse
Oncorena AB is a Swedish pharmaceutical company founded in 2011, currently headquartered in Lund. Their primary mission is to transform a natural substance into a breakthrough treatment for patients with metastatic renal cancer. The company is developing ONC175, the synthetically produced active ing...
Tagger
Nøkkelord
Bedriftsinformasjon
- Bransje
- Annan naturvetenskaplig och teknisk forskning och utveckling
- Juridisk form
- Aktiebolag
- MVA-nummer
- SE556864080801
Beslutningstakere
3 kontakter i FunnelfeedrBörje Haraldsson
CEO
Susanna Dahlgren
Chief Operating Officer
Åsa Holmgren
Head of Regulatory Affairs
Lignende bedrifter
20 lignende bedrifter i FunnelfeedrAbarceo Pharma AB
5–9 ansatteDeveloping novel small molecule therapeutics targeting VDAC1 for diabetes.
Lokon Pharma AB
10–19 ansatteDeveloping novel gene engineering vectors for cancer immunotherapy.
ALLUCENT (NL) B.V.
5–9 ansatteGlobal full-service CRO accelerating therapy development for small biotechs.
Ascelia Pharma AB
Biotech developing novel orphan oncology drugs for unmet needs.
Ribocure Pharmaceuticals AB
20–49 ansatteClinical stage biotech developing cutting-edge RNA therapeutics for rare diseases.
Utforsk mer
Spørsmål om Oncorena AB
Vil du se Funnelfeedr i aksjon?
Book en gratis demo og oppdag hvordan Funnelfeedr hjelper deg med å finne og konvertere dine ideelle kunder.
Book en demo